Maintenance after GLP-1: what happens when you stop, and how to protect what you built

The medication ends. The body composition you built doesn't have to. Most users who stop a GLP-1 either taper deliberately or stop because of cost, supply, side effects, or pregnancy. Within a year of stopping, the published data shows the majority regain a meaningful fraction of the weight they lost — but the same data shows that users who maintained the protein and resistance training plan during the medication period regain less, and what they regain is more fat-dominant than the original loss. The maintenance plan after a GLP-1 is the same plan you should have been running during it, with appetite operating under its own rules again.

Why people stop, and what changes when they do

The reasons vary by region. In the United States: insurance coverage cycles, plan changes, side-effect fatigue. In South Africa: cost, supply, switching to compounded. In the EU: stigma, side-effect intolerance, pregnancy. Whatever the reason, the physiological reality is the same — appetite begins to return as the medication clears, typically within 4 to 8 weeks of the last dose for weekly semaglutide and roughly 6 to 10 weeks for tirzepatide.

The window matters. Most weight regain in the published data clusters in months 3 through 12 after stopping. Months 1 and 2 are usually flat — the body's set point hasn't reasserted yet. The protein and training habits you build in those first eight weeks largely determine the next year.

Three regain patterns from the data

Patterns synthesised from published post-discontinuation data (STEP-1 extension, SURMOUNT-4 maintenance arm, observational cohorts). Individual variance is wide.

Taper or hard stop

Both are legitimate. The choice belongs to you and your prescriber, and the decision changes the maintenance plan significantly.

• Hard stop. Most users default to this — last shot, done. Appetite returns over weeks. Easier to schedule, more dramatic appetite shift, higher regain risk without compensating habits.
• Taper down. Step down dose over 8 to 16 weeks. Smoother appetite transition. Slightly more clinic visits, slightly lower regain risk.
• Low-dose maintenance. Many users (with prescriber agreement) stay on a low maintenance dose long-term — 0.25-0.5 mg semaglutide weekly or equivalent. This is essentially continuous medication; the regain risk drops sharply, the cost continues.

Muscle preservation in maintenance is non-negotiable

The single biggest determinant of whether your post-GLP-1 year goes well is whether you continued resistance training while you were on the medication. Users who didn't train during the active phase don't have the strength baseline to draw on; users who did, do. If you've been training consistently while losing weight, you have the platform.

The maintenance training plan is the same as the loss-phase plan: 2 to 4 resistance sessions per week, all major muscle groups, progressive overload. Protein remains at 1.2 to 1.6 g/kg/day. Cardiovascular work is fine and useful for cardiovascular health, but the muscle preservation engine is the resistance work. See muscle preservation and the protein playbook.

Living with returning appetite

The first month is psychologically harder than the first month of starting a GLP-1. On the way up, you noticed hunger disappearing — quiet, welcome. On the way down, you notice hunger returning — loud, intrusive. Many users describe it as "food sounds different again."

Two practical strategies that hold up across the data. First, keep the same eating rhythm you settled into on the medication — three or four meals a day, protein first, vegetables and carbohydrates around them. Don't return to old eating patterns by default. Second, find the calorie maintenance level and stay near it. Free-eat days reliably trigger overshoot for several days after.

Tracking maintenance in Muscle Guard

The maintenance feature launches later in 2026. It includes: a maintenance-mode Muscle Guard Score that weights protein and training more heavily than weight movement; a weekly trend view that highlights regain risk early; a Doctor PDF preset for post-discontinuation consults; and reminders calibrated for the longer cadence (clinic visits typically every 8 to 12 weeks rather than every 4).

Until that feature lands, the existing Score works for maintenance with a small caveat: a stable-weight week is read as "okay" rather than "excellent". Use protein, training, and waist measurement as your leading indicators rather than the scale alone.

Frequently asked questions

Start your free 7-day Pro trial →